Clinical and biological activity of the interferons in hematologic malignancies.
Gutterman
J U
JU
M.D. Anderson Hospital and Tumor Institute, Houston, Texas 77030.
D000912:Antibodies, Neoplasm / Q000096:biosynthesis; D002986:Clinical Trials as Topic; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D007938:Leukemia / Q000628:therapy*; D007943:Leukemia, Hairy Cell / Q000276:immunology / Q000628:therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000628:therapy; D008223:Lymphoma / Q000628:therapy*; D010677:Philadelphia Chromosome; D011994:Recombinant Proteins / Q000627:therapeutic use
D000912:Antibodies, Neoplasm; D011994:Recombinant Proteins; D007372:Interferons